Tender detail

Conclusion of a non-exclusive discount agreement for mometasone (solution dosage form only), ATC D07AC13, for 1 January 2027 to 31 December 2028, with one 12-month extension option

Summary

DAK-Gesundheit is seeking non-exclusive pharmaceutical discount agreements for medicines containing the active ingredient mometasone, in solution dosage form only (ATC D07AC13). The agreements are intended to run from 1 January 2027 to 31 December 2028, with an option to extend once for 12 months; they end earlier if an exclusive agreement takes effect.

Reference number
642b0886-2683-4ef2-875e-9d0b0005318e
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2029-11-05
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.